Evofem Biosciences (EVFM) Net Equity Issued and Repurchased (2014 - 2024)
Evofem Biosciences' Net Equity Issued and Repurchased came in at $5 million for FY2024, compared with $290,000 in FY2023.
Powered by 
Analysis
Evofem Biosciences (EVFM) Net Equity Issued and Repurchased (2014 - 2024) Analysis & Trends
Going back to FY2014, Evofem Biosciences' Net Equity Issued and Repurchased data covers 11 years.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -41.9% (FY2019 to FY2024).
- The five-year range for annual Net Equity Issued and Repurchased is $290,000 (FY2023) to $25.21 million (FY2022).
- Per Business Quant, earlier years put Net Equity Issued and Repurchased at $290,000 in FY2023 (-98.8%), $25.21 million in FY2022 (+152.1%), $10 million in FY2021 and $447,000 in FY2020 (-99.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 3.74 Mn |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 116,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 99,000.00 |
| Mar 31, 2023 | 61,000.00 |
| Dec 31, 2022 | -7.46 Mn |
| Sep 30, 2022 | 30.97 Mn |
| Jun 30, 2022 | 21.10 Mn |
| Mar 31, 2022 | 5.48 Mn |
| Dec 31, 2021 | 81.64 Mn |
| Sep 30, 2021 | 110,000.00 |
| Jun 30, 2021 | -27.81 Mn |
| Mar 31, 2021 | 28.05 Mn |
| Dec 31, 2020 | 110,000.00 |
| Jun 30, 2020 | 106.27 Mn |
| Mar 31, 2020 | 1.58 Mn |
| Dec 31, 2019 | 3.22 Mn |
| Jun 30, 2019 | 75.45 Mn |
| Mar 31, 2019 | 12.55 Mn |
API Access
Evofem Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();